# PREP (Pre-Exposure Prophylaxis) of COVID-19

> **NCT05461378** · — · COMPLETED · sponsor: **Ghady Haidar** · enrollment: 138 (actual)

## Conditions studied

- Immuno-Deficiency
- COVID-19

## Interventions

- **DRUG:** Evusheld

## Key facts

- **NCT ID:** NCT05461378
- **Lead sponsor:** Ghady Haidar
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-26
- **Primary completion:** 2024-01-29
- **Final completion:** 2024-01-29
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2024-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05461378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05461378, "PREP (Pre-Exposure Prophylaxis) of COVID-19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05461378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*